What is Central Garden & Pet Company's earnings per share (EPS)?

Central Garden & Pet Company (CENTA) reported diluted earnings per share of $2.55 for fiscal year 2025. This represents a 57.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Central Garden & Pet Company (CENTA) Financials

CENTA

Trailing 12 months to June 27, 2026

Revenue $3.1B -1.2% YoY

Net Income $166.3M +20.1% YoY

EPS (Diluted) $2.70 +22.7% YoY

Free Cash Flow $345.6M +10.7% YoY

Market Cap $2.2B as of Oct 10, 2026

Price / Sales 0.7x on $3.1B revenue, trailing 12 months to June 27, 2026

Price / Earnings 13.2x on $166.3M net income, trailing 12 months to June 27, 2026

Price / Book 1.3x on $1.7B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 27, 2026 Reported Aug 6, 2026 Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CENTA SEC filings page.

Central Garden & Pet Company (CENTA) reported $3.1B in revenue over the twelve months to Jun 27, 2026, down 1.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CENTA FY2025 2026-10-03

With sales edging lower, Central Garden & Pet’s 2025 earnings rebound came mainly from margin recovery, while cash generation remained positive but less aligned.

The 2025 rebound was margin-led: sales fell to $3.1B, but gross margin reached 31.9%, so improved profit came from earning more on each dollar sold rather than from volume growth. Operating cash flow fell to $332.5M even as net income rose to $162.8M, meaning accounting recovery outpaced cash conversion, although cash generation still exceeded reported profit.

Operating income recovered to $250M while sales remained below FY2024, pointing to margin improvement and cost absorption rather than demand expansion. SG&A eased to $747M from FY2024’s $758M, reinforcing that the 2025 margin step-up was not solely a revenue effect.

Debt-to-equity fell from 1.0x in FY2021 to 0.8x in FY2025, showing equity grew faster than debt even as long-term borrowing stayed broadly steady. A 3.7x current ratio alongside $291M of free cash flow describes a business funding reinvestment internally while maintaining substantial current-asset coverage.

Financial Health Signals

Financial Health Score 59/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Central Garden & Pet Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Central Garden & Pet Company has an operating margin of 8.0%, meaning the company retains $8 of operating profit per $100 of revenue. This strong profitability earns a score of 66/100, reflecting efficient cost management and pricing power. This is up from 5.8% the prior year.

Growth

Central Garden & Pet Company's revenue declined 2.2% year-over-year, from $3.2B to $3.1B. This contraction results in a growth score of 21/100.

Leverage

Central Garden & Pet Company has a moderate D/E ratio of 0.75. This balance of debt and equity financing earns a leverage score of 49/100.

Liquidity

With a current ratio of 3.67, Central Garden & Pet Company holds $3.67 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.

Cash Flow

Central Garden & Pet Company converts 9.3% of revenue into free cash flow ($291.1M). This strong cash generation earns a score of 65/100.

Returns

Central Garden & Pet Company earns a strong 10.3% return on equity (ROE), meaning it generates $10 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 66/100. This is up from 6.9% the prior year.

Altman Z-Score Grey Zone

2.60

Central Garden & Pet Company scores 2.60, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

7/8

Central Garden & Pet Company passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.04x

For every $1 of reported earnings, Central Garden & Pet Company generates $2.04 in operating cash flow ($332.5M OCF vs $162.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

4.33x

Central Garden & Pet Company earns $4.33 in operating income for every $1 of interest expense ($250.0M vs $57.7M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$882.4M

YoY-8.2%

QoQ-2.6%

5Y CAGR-3.2%

10Y CAGR+4.4%

Central Garden & Pet Company generated $882.4M in revenue in Q3 2026. This represents a decrease of 8.2% from the same quarter a year earlier. Against the prior quarter it is down 2.6%.

EBITDA

$145.5M

YoY-7.1%

QoQ+8.1%

5Y CAGR+1.6%

Central Garden & Pet Company's EBITDA was $145.5M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.1% from the same quarter a year earlier. Against the prior quarter it is up 8.1%.

Net Income

$89.9M

YoY-5.4%

QoQ+13.1%

5Y CAGR+3.4%

10Y CAGR+10.8%

Central Garden & Pet Company reported $89.9M in net income in Q3 2026. This represents a decrease of 5.4% from the same quarter a year earlier. Against the prior quarter it is up 13.1%.

EPS (Diluted)

$1.45

YoY-4.6%

QoQ+13.3%

5Y CAGR+1.1%

10Y CAGR+8.9%

Central Garden & Pet Company earned $1.45 per diluted share (EPS) in Q3 2026. This represents a decrease of 4.6% from the same quarter a year earlier. Against the prior quarter it is up 13.3%.

Cash & Balance Sheet

Free Cash Flow

$314.9M

YoY+25.1%

QoQ+624.0%

5Y CAGR+2.7%

10Y CAGR+8.9%

Central Garden & Pet Company generated $314.9M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 25.1% from the same quarter a year earlier. Against the prior quarter it is up 624.0%.

Cash & Debt

$996.7M

YoY+39.8%

QoQ+52.6%

5Y CAGR+14.0%

10Y CAGR+37.9%

Central Garden & Pet Company held $996.7M in cash against $1.2B in long-term debt as of Q3 2026.

Shares Outstanding

Diluted avg 62M

Central Garden & Pet Company had a weighted average of 62M diluted shares in Q3 2026; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

35.9%

YoY+1.4pp

QoQ+2.9pp

5Y change+5.0pp

10Y change+4.0pp

Central Garden & Pet Company's gross margin was 35.9% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.9 percentage points.

Operating Margin

14.3%

YoY+0.2pp

QoQ+1.7pp

5Y change+3.3pp

Central Garden & Pet Company's operating margin was 14.3% in Q3 2026, reflecting core business profitability. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Net Margin

10.2%

YoY+0.3pp

QoQ+1.4pp

5Y change+2.8pp

10Y change+4.6pp

Central Garden & Pet Company's net profit margin was 10.2% in Q3 2026, showing the share of revenue converted to profit. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Return on Equity

5.1%

YoY-0.8pp

QoQ+0.3pp

5Y change-1.0pp

10Y change-0.7pp

Central Garden & Pet Company's ROE was 5.1% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Capital Allocation

Share Buybacks

$951K

YoY-98.3%

QoQ-87.9%

5Y CAGR-22.3%

10Y CAGR-18.9%

Central Garden & Pet Company spent $951K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 98.3% from the same quarter a year earlier. Against the prior quarter it is down 87.9%.

Capital Expenditures

$12.6M

YoY-8.9%

QoQ+20.4%

5Y CAGR-11.7%

10Y CAGR+6.5%

Central Garden & Pet Company invested $12.6M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 8.9% from the same quarter a year earlier. Against the prior quarter it is up 20.4%.

R&D Spending

Not reported for Q3 2026.

CENTA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CENTA quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.1B	$3.1B-2.2%	$3.2B-3.3%	$3.3B-0.9%	$3.3B+1.1%	$3.3B+22.6%	$2.7B+13.1%	$2.4B+7.6%	$2.2B+7.8%	$2.1B+12.3%	$1.8B+10.8%	$1.7B+2.9%	$1.6B-3.0%	$1.7B-2.7%	$1.7B+4.4%	$1.6B
Cost of Revenue	$2.1B	$2.1B-5.5%	$2.3B-4.5%	$2.4B+0.7%	$2.3B+0.6%	$2.3B+22.8%	$1.9B+13.1%	$1.7B+9.0%	$1.5B+8.3%	$1.4B+11.4%	$1.3B+9.7%	$1.2B+1.1%	$1.2B-3.3%	$1.2B+0.3%	$1.2B+4.5%	$1.1B
Gross Profit	$1.0B	$997.3M+5.7%	$943.7M-0.3%	$946.8M-4.6%	$992.3M+2.2%	$970.9M+21.9%	$796.6M+13.1%	$704.0M+4.2%	$675.4M+6.7%	$632.8M+14.4%	$553.0M+13.3%	$488.1M+7.5%	$454.0M-2.1%	$463.9M-9.8%	$514.2M+4.1%	$493.9M
SG&A Expenses	$753.7M	$747.3M-1.5%	$758.3M+3.0%	$736.2M+0.5%	$732.3M+2.2%	$716.4M+19.7%	$598.6M+8.4%	$552.0M+8.6%	$508.0M+6.6%	$476.7M+13.0%	$421.9M+8.4%	$389.3M-2.1%	$397.8M-4.4%	$416.0M-5.4%	$439.7M+7.6%	$408.7M
Operating Income	$249.9M	$250.0M+34.9%	$185.4M-12.0%	$210.6M-19.0%	$260.0M+2.2%	$254.5M+28.5%	$198.0M+30.2%	$152.1M-9.1%	$167.3M+7.2%	$156.1M+20.7%	$129.4M+41.5%	$91.4M+62.7%	$56.2M+40.0%	$40.2M-46.0%	$74.4M-12.6%	$85.2M
EBITDA	N/A	$334.9M+21.3%	$276.2M-7.4%	$298.3M-12.5%	$341.0M+3.6%	$329.2M+30.0%	$253.3M+24.9%	$202.9M-5.4%	$214.5M+7.9%	$198.8M+17.4%	$169.4M+35.3%	$125.1M+36.0%	$92.0M+25.8%	$73.1M-30.3%	$104.8M-7.8%	$113.7M
Interest Expense	$57.2M	$57.7M+0.3%	$57.5M+0.9%	$57.0M-2.1%	$58.3M-0.6%	$58.6M+33.1%	$44.0M+3.3%	$42.6M+8.7%	$39.2M+38.9%	$28.2M-34.2%	$42.8M+7.0%	$40.0M-6.6%	$42.8M-0.6%	$43.1M+6.9%	$40.3M+6.0%	$38.0M
Income Tax	$52.8M	$52.8M+59.4%	$33.1M-8.9%	$36.3M-21.4%	$46.2M+10.0%	$42.0M+30.5%	$32.2M+21.1%	$26.6M+705.0%	$3.3M-92.9%	$46.7M+94.2%	$24.1M+29.8%	$18.5M+358.2%	$4.0M+256.1%	-$2.6M-120.2%	$12.8M-34.6%	$19.6M
Net Income	$166.3M	$162.8M+50.8%	$108.0M-14.1%	$125.6M-17.4%	$152.2M+0.3%	$151.7M+25.7%	$120.7M+30.1%	$92.8M-24.9%	$123.6M+56.8%	$78.8M+77.1%	$44.5M+39.2%	$32.0M+263.1%	$8.8M+556.4%	-$1.9M-109.1%	$21.2M-25.2%	$28.3M
EPS (Basic)	N/A	$2.58+57.3%	$1.64-14.6%	$1.92-16.2%	$2.29-18.5%	$2.81+26.0%	$2.23+36.8%	$1.63-31.8%	$2.39+52.2%	$1.57+72.5%	$0.91+37.9%	$0.66+266.7%	$0.18+550.0%	-$0.04-109.1%	$0.44-12.0%	$0.50
EPS (Diluted)	$2.70	$2.55+57.4%	$1.62-13.8%	$1.88-16.1%	$2.24-18.5%	$2.75+25.0%	$2.20+36.6%	$1.61-30.6%	$2.32+52.6%	$1.52+74.7%	$0.87+35.9%	$0.64+255.6%	$0.18+550.0%	-$0.04-109.1%	$0.44-12.0%	$0.50
Diluted Shares (Avg)	N/A	64M-4.6%	67M+0.1%	67M-1.8%	68M+23.1%	55M+0.9%	55M-5.0%	58M+8.0%	53M+2.9%	52M+1.5%	51M+2.9%	50M+0.5%	49M+2.7%	48M-0.6%	48M-14.6%	57M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$882.4M-8.2%	$906.2M+8.7%	$617.4M-6.0%	$678.2M+1.3%	$960.9M-3.6%	$833.5M-7.4%	$656.4M+3.5%	$669.5M-10.7%
Cost of Revenue	$565.4M-10.1%	$606.6M+8.2%	$426.8M-7.4%	$481.6M-3.8%	$628.9M-7.4%	$560.5M-9.8%	$460.7M+1.1%	$500.5M-9.4%
Gross Profit	$316.9M-4.5%	$299.6M+9.7%	$190.6M-2.6%	$196.5M+16.3%	$332.0M+4.7%	$273.1M-2.1%	$195.7M+9.4%	$169.0M-14.4%
SG&A Expenses	$191.1M-3.0%	$185.6M+3.3%	$174.1M+3.8%	$202.9M+0.8%	$196.9M-2.1%	$179.8M-3.1%	$167.7M-1.6%	$201.4M+7.1%
Operating Income	$125.8M-6.9%	$113.9M+22.1%	$16.5M-40.9%	-$6.4M+80.3%	$135.1M+16.6%	$93.3M-0.1%	$28.0M+232.8%	-$32.4M-445.9%
EBITDA	$145.5M-7.1%	$134.6M+18.1%	$37.2M-25.5%	$14.4M+249.2%	$156.6M+13.0%	$114.0M-2.0%	$49.9M+61.3%	-$9.7M-130.6%
Interest Expense	$14.3M-0.6%	$14.1M-3.0%	$14.5M+0.3%	$14.4M+1.7%	$14.4M-2.4%	$14.5M+0.9%	$14.5M+1.1%	$14.1M+7.4%
Income Tax	$29.6M-7.3%	$24.5M+23.2%	$2.1M-52.1%	-$3.4M+67.8%	$31.9M+25.4%	$19.9M+4.0%	$4.4M+602.2%	-$10.6M-242.8%
Net Income	$89.9M-5.4%	$79.4M+24.8%	$6.8M-51.2%	-$9.8M+71.3%	$95.0M+19.2%	$63.6M+2.7%	$14.0M+3157.9%	-$34.2M-1304.9%
EPS (Basic)	$1.46-4.6%	$1.29+30.3%	$0.11-50.0%	-$0.14+73.6%	$1.53+26.4%	$0.99+5.3%	$0.22+2100.0%	-$0.53-1160.0%
EPS (Diluted)	$1.45-4.6%	$1.28+30.6%	$0.11-47.6%	-$0.14+72.5%	$1.52+27.7%	$0.98+5.4%	$0.21	-$0.51-1375.0%
Diluted Shares (Avg)	62M-1.1%	62M-4.6%	62M-5.2%	N/A	63M-6.5%	65M-2.9%	65M	N/A

Not reported in any period shown, so not listed: R&D Expenses.

CENTA Balance Sheet

CENTA quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.6B+2.0%	$3.6B+5.2%	$3.4B+2.9%	$3.3B+5.3%	$3.1B+33.2%	$2.3B+15.5%	$2.0B+6.2%	$1.9B+45.9%	$1.3B+10.7%	$1.2B+7.2%	$1.1B-4.1%	$1.1B-1.1%	$1.2B+1.0%	$1.1B+5.2%	$1.1B
Current Assets	$2.0B+4.7%	$1.9B+10.5%	$1.7B+9.9%	$1.6B+0.7%	$1.5B+1.2%	$1.5B+16.7%	$1.3B+7.4%	$1.2B+78.2%	$683.1M0.0%	$683.3M+4.5%	$653.8M-2.6%	$671.6M-0.2%	$672.7M+3.2%	$651.8M+8.2%	$602.6M
Cash & Equivalents	$882.5M+17.1%	$753.5M+54.2%	$488.7M+175.4%	$177.4M-58.4%	$426.4M-34.7%	$652.7M+31.1%	$497.7M+3.2%	$482.1M+1388.1%	$32.4M-65.2%	$93.0M+95.4%	$47.6M-39.5%	$78.7M+419.1%	$15.2M-68.7%	$48.5M+302.9%	$12.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$10.0M-43.9%	$17.8M-21.5%	$22.7M+27.4%	$17.8M
Inventory	$722.1M-4.7%	$757.9M-9.6%	$838.2M-10.6%	$938.0M+36.9%	$685.2M+55.9%	$439.6M-5.7%	$466.2M+9.0%	$427.8M+12.0%	$382.1M+5.6%	$362.0M+7.8%	$335.9M+2.9%	$326.4M-16.7%	$391.9M+18.8%	$330.0M+0.1%	$329.5M
Accounts Receivable	$325.3M-0.3%	$326.2M-2.0%	$332.9M-11.7%	$376.8M-2.2%	$385.4M-1.6%	$391.8M+30.5%	$300.1M+8.8%	$275.9M+16.0%	$237.9M+18.3%	$201.2M-3.0%	$207.4M+7.1%	$193.7M-0.3%	$194.3M-4.0%	$202.4M+3.6%	$195.4M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$554.7M+0.6%	$551.4M+0.9%	$546.4M0.0%	$546.4M+47.9%	$369.4M+27.4%	$290.0M+1.4%	$286.1M+1.7%	$281.2M+9.7%	$256.3M+10.8%	$231.4M+10.7%	$209.1M0.0%	$209.1M+1.6%	$205.8M-2.1%	$210.2M0.0%	$210.2M
Total Liabilities	$2.0B+2.2%	$2.0B+3.7%	$1.9B-1.1%	$1.9B+2.8%	$1.9B+50.0%	$1.3B+22.7%	$1.0B+7.8%	$954.8M+42.2%	$671.2M+6.9%	$627.7M+5.3%	$595.8M-10.3%	$664.0M-4.1%	$692.5M+1.0%	$685.6M+7.8%	$636.2M
Current Liabilities	$538.8M+4.5%	$515.4M+12.5%	$458.0M-1.7%	$465.9M-10.8%	$522.3M+18.6%	$440.3M+58.1%	$278.5M+30.8%	$213.0M-3.3%	$220.2M+8.9%	$202.2M+14.3%	$176.9M+2.2%	$173.1M-5.1%	$182.3M-11.7%	$206.5M+7.6%	$191.9M
Non-Current Liabilities	$1.5B+1.4%	$1.5B+0.9%	$1.5B-0.9%	$1.5B+8.0%	$1.4B+66.9%	$822.3M+9.6%	$750.5M+1.2%	$741.8M+64.5%	$451.0M+6.0%	$425.4M+1.6%	$418.9M-14.7%	$490.9M-3.8%	$510.2M+6.5%	$479.1M+7.8%	$444.3M
Long-Term Debt	$1.2B+0.2%	$1.2B+0.2%	$1.2B+0.1%	$1.2B+0.1%	$1.2B+70.7%	$694.0M+0.1%	$693.0M+0.1%	$692.0M+75.1%	$395.3M+0.1%	$394.8M-0.5%	$396.7M-11.8%	$449.9M-4.8%	$472.4M+5.1%	$449.5M+3.3%	$435.3M
Total Equity	$1.6B+1.8%	$1.6B+7.2%	$1.5B+8.8%	$1.3B+9.1%	$1.2B+13.5%	$1.1B+8.1%	$996.0M+4.6%	$952.4M+49.8%	$635.7M+14.9%	$553.0M+9.4%	$505.3M+4.2%	$484.7M+3.4%	$468.7M+1.0%	$463.9M+1.6%	$456.8M
Retained Earnings	$1.0B+5.8%	$959.5M+11.7%	$859.4M+13.8%	$755.3M+16.9%	$646.1M+26.5%	$510.8M+21.1%	$421.7M+16.2%	$362.9M+51.6%	$239.3M+49.1%	$160.5M+38.4%	$116.0M+34.3%	$86.4M+11.3%	$77.6M-2.7%	$79.7M+35.0%	$59.0M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$3.8B+3.6%	$3.7B+3.2%	$3.6B+3.0%	$3.6B+2.0%	$3.7B+1.4%	$3.6B+2.5%	$3.5B+3.3%	$3.6B+5.2%
Current Assets	$2.1B+6.7%	$2.1B+5.7%	$2.0B+4.1%	$2.0B+4.7%	$2.0B+4.7%	$2.0B+6.7%	$1.9B+10.1%	$1.9B+10.5%
Cash & Equivalents	$996.7M+39.8%	$653.2M+26.4%	$721.1M+16.7%	$882.5M+17.1%	$713.0M+25.0%	$516.7M+71.5%	$618.0M+81.0%	$753.5M+54.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$631.6M-12.1%	$782.3M-5.1%	$836.3M+2.5%	$722.1M-4.7%	$718.3M-8.5%	$824.3M-9.9%	$815.8M-14.0%	$757.9M-9.6%
Accounts Receivable	$460.2M-12.0%	$603.2M+4.2%	$357.8M-10.4%	$325.3M-0.3%	$522.7M+3.0%	$578.9M+0.1%	$399.4M+7.7%	$326.2M-2.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$545.8M-1.6%	$554.7M0.0%	$554.7M+0.6%	$554.7M+0.6%	$554.7M+1.5%	$554.7M+1.5%	$551.4M+0.9%	$551.4M+0.9%
Total Liabilities	$2.0B-1.2%	$2.1B+0.3%	$2.1B+2.5%	$2.0B+2.2%	$2.1B+2.7%	$2.1B+2.9%	$2.0B+2.3%	$2.0B+3.7%
Current Liabilities	$563.7M+0.3%	$605.2M+1.3%	$574.0M+5.6%	$538.8M+4.5%	$562.2M+7.8%	$597.7M+7.4%	$543.7M+10.0%	$515.4M+12.5%
Non-Current Liabilities	$1.5B-1.7%	$1.5B-0.1%	$1.5B+1.4%	$1.5B+1.4%	$1.5B+0.9%	$1.5B+1.2%	$1.5B-0.2%	$1.5B+0.9%
Long-Term Debt	$1.2B+0.2%	$1.2B+0.2%	$1.2B+0.2%	$1.2B+0.2%	$1.2B+0.2%	$1.2B+0.1%	$1.2B+0.1%	$1.2B+0.2%
Total Equity	$1.7B+9.9%	$1.7B+7.1%	$1.6B+3.7%	$1.6B+1.8%	$1.6B-0.3%	$1.5B+2.0%	$1.5B+4.6%	$1.6B+7.2%
Retained Earnings	$1.2B+14.7%	$1.1B+12.0%	$1.0B+7.8%	$1.0B+5.8%	$1.0B+2.4%	$969.7M+5.3%	$936.3M+9.0%	$959.5M+11.7%

CENTA Cash Flow Statement

CENTA quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$390.3M	$332.5M-15.8%	$394.9M+3.5%	$381.6M+1221.5%	-$34.0M-113.6%	$250.8M-5.1%	$264.3M+28.9%	$205.0M+79.6%	$114.1M-0.2%	$114.3M-24.5%	$151.4M+73.2%	$87.4M-30.9%	$126.5M+547.2%	-$28.3M-131.7%	$89.2M+74.8%	$51.0M
Depreciation & Amortization	N/A	$84.9M-6.5%	$90.8M+3.5%	$87.7M+8.3%	$80.9M+8.3%	$74.7M+35.0%	$55.4M+8.9%	$50.8M+7.7%	$47.2M+10.5%	$42.7M+6.8%	$40.0M+18.7%	$33.7M-5.8%	$35.8M+8.5%	$33.0M+8.4%	$30.4M+6.5%	$28.6M
Stock-Based Compensation	N/A	$21.1M+2.3%	$20.6M-26.5%	$28.0M+8.4%	$25.8M+11.6%	$23.1M+21.8%	$19.0M+29.5%	$14.7M+26.4%	$11.6M+4.4%	$11.1M+33.0%	$8.4M+0.5%	$8.3M+8.3%	$7.7M-51.7%	$15.9M+111.6%	$7.5M+0.8%	$7.4M
Capital Expenditures	$44.7M	$41.4M-4.0%	$43.1M-20.1%	$54.0M-53.2%	$115.2M+43.4%	$80.3M+86.6%	$43.1M+36.3%	$31.6M-16.6%	$37.8M-15.3%	$44.7M+61.7%	$27.6M+25.4%	$22.0M+28.3%	$17.2M-31.8%	$25.2M-36.4%	$39.6M+25.4%	$31.6M
Free Cash Flow	$345.6M	$291.1M-17.2%	$351.8M+7.4%	$327.7M+319.6%	-$149.2M-187.5%	$170.5M-22.9%	$221.2M+27.6%	$173.4M+127.4%	$76.3M+9.5%	$69.7M-43.7%	$123.8M+89.2%	$65.4M-40.1%	$109.3M+304.5%	-$53.5M-207.8%	$49.6M+155.0%	$19.4M
Investing Cash Flow	-$71.8M	-$44.9M+57.3%	-$105.2M-204.2%	-$34.6M+75.8%	-$143.0M+84.1%	-$899.4M-1769.5%	-$48.1M+36.9%	-$76.3M+45.9%	-$140.9M+13.5%	-$162.8M-78.6%	-$91.2M-82.9%	-$49.9M	N/A	-$25.1M+43.5%	-$44.5M+20.9%	-$56.2M
Financing Cash Flow	-$32.7M	-$156.6M-515.8%	-$25.4M+32.3%	-$37.6M+43.8%	-$66.8M-115.9%	$420.5M+794.3%	-$60.6M+45.3%	-$110.8M-123.3%	$474.8M+4668.7%	-$10.4M+26.6%	-$14.2M+79.3%	-$68.4M	N/A	$20.3M+336.8%	-$8.6M+88.4%	-$74.0M
Share Buybacks	$29.2M	$155.1M+544.1%	$24.1M-35.2%	$37.2M-40.3%	$62.3M+123.3%	$27.9M-52.8%	$59.1M-6.1%	$63.0M+356.4%	$13.8M-49.9%	$27.6M+153.4%	$10.9M-41.2%	$18.5M+693.2%	$2.3M-14.6%	$2.7M-89.0%	$24.8M-77.2%	$108.7M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$327.5M+23.3%	-$49.6M-5.9%	-$70.2M-2.0%	$182.7M-10.0%	$265.5M-7.2%	-$46.9M-91.1%	-$68.8M+1.4%	$203.1M+31.8%
Depreciation & Amortization	$19.6M-8.6%	$20.7M+0.2%	$20.7M-5.8%	$20.8M-8.4%	$21.5M-5.4%	$20.6M-9.5%	$21.9M-2.7%	$22.7M+2.4%
Stock-Based Compensation	N/A	N/A	$4.8M-12.4%	N/A	N/A	N/A	$5.5M-8.5%	N/A
Capital Expenditures	$12.6M-8.9%	$10.5M-1.9%	$10.8M+77.2%	$10.8M+8.0%	$13.8M+1.5%	$10.7M+14.0%	$6.1M-39.8%	$10.0M-23.5%
Free Cash Flow	$314.9M+25.1%	-$60.1M-4.5%	-$81.0M-8.1%	$171.9M-11.0%	$251.7M-7.6%	-$57.5M-69.8%	-$74.9M+6.2%	$193.0M+37.0%
Investing Cash Flow	$17.3M+225.2%	-$10.5M+2.6%	-$67.8M-620.0%	-$10.8M-2.3%	-$13.8M+3.2%	-$10.8M-9.9%	-$9.4M+86.6%	-$10.6M-254.3%
Financing Cash Flow	-$965K+98.3%	-$7.9M+82.2%	-$23.5M+57.6%	-$361K+96.2%	-$56.6M-1894.3%	-$44.3M-722.1%	-$55.4M-612.2%	-$9.4M-142.6%
Share Buybacks	$951K-98.3%	$7.9M-82.2%	$20.0M-63.0%	$332K-96.4%	$56.5M+1992.6%	$44.2M+737.3%	$54.0M+697.4%	$9.3M+148.4%

Not reported in any period shown, so not listed: Dividends Paid.

CENTA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CENTA quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	31.9%+2.4pp	29.5%+0.9pp	28.6%-1.1pp	29.7%+0.3pp	29.4%-0.2pp	29.5%0.0pp	29.5%-1.0pp	30.5%-0.3pp	30.8%+0.6pp	30.2%+0.7pp	29.6%+1.3pp	28.3%+0.2pp	28.1%-2.2pp	30.2%-0.1pp	30.3%
Operating Margin	8.0%+2.2pp	5.8%-0.6pp	6.4%-1.4pp	7.8%+0.1pp	7.7%+0.4pp	7.3%+1.0pp	6.4%-1.2pp	7.5%-0.1pp	7.6%+0.5pp	7.1%+1.5pp	5.5%+2.0pp	3.5%+1.1pp	2.4%-1.9pp	4.4%-0.9pp	5.2%
Net Margin	5.2%+1.8pp	3.4%-0.4pp	3.8%-0.8pp	4.6%0.0pp	4.6%+0.1pp	4.5%+0.6pp	3.9%-1.7pp	5.6%+1.7pp	3.8%+1.4pp	2.4%+0.5pp	1.9%+1.4pp	0.5%+0.7pp	-0.1%-1.4pp	1.3%-0.5pp	1.7%
Return on Equity	10.3%+3.4pp	6.9%-1.7pp	8.7%-2.7pp	11.4%-1.0pp	12.4%+1.2pp	11.2%+1.9pp	9.3%-3.7pp	13.0%+0.6pp	12.4%+4.3pp	8.1%+1.7pp	6.3%+4.5pp	1.8%+2.2pp	-0.4%-5.0pp	4.6%-1.6pp	6.2%
Return on Assets	4.5%+1.5pp	3.0%-0.7pp	3.7%-0.9pp	4.6%-0.2pp	4.9%-0.3pp	5.2%+0.6pp	4.6%-1.9pp	6.5%+0.4pp	6.0%+2.3pp	3.8%+0.9pp	2.9%+2.1pp	0.8%+0.9pp	-0.2%-2.0pp	1.8%-0.8pp	2.6%
Current Ratio	3.670.0x	3.66-0.1x	3.73+0.4x	3.34+0.4x	2.96-0.5x	3.46-1.2x	4.69-1.0x	5.72+2.6x	3.10-0.3x	3.38-0.3x	3.70-0.2x	3.88+0.2x	3.69+0.5x	3.160.0x	3.14
Debt-to-Equity	0.750.0x	0.76-0.1x	0.82-0.1x	0.89-0.1x	0.97+0.3x	0.64-0.1x	0.700.0x	0.73+0.1x	0.62-0.1x	0.71-0.1x	0.79-0.1x	0.93-0.1x	1.010.0x	0.970.0x	0.95
Asset Turnover	0.860.0x	0.90-0.1x	0.980.0x	1.020.0x	1.06-0.1x	1.150.0x	1.180.0x	1.16-0.4x	1.570.0x	1.550.0x	1.50+0.1x	1.400.0x	1.42-0.1x	1.480.0x	1.49
FCF Margin	9.3%-1.7pp	11.0%+1.1pp	9.9%+14.4pp	-4.5%-9.6pp	5.2%-3.1pp	8.2%+0.9pp	7.3%+3.8pp	3.4%+0.1pp	3.4%-3.4pp	6.8%+2.8pp	4.0%-2.8pp	6.8%+10.0pp	-3.2%-6.2pp	2.9%+1.7pp	1.2%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	35.9%+1.4pp	33.1%+0.3pp	30.9%+1.1pp	29.0%+3.7pp	34.5%+2.7pp	32.8%+1.8pp	29.8%+1.6pp	25.2%-1.1pp
Operating Margin	14.3%+0.2pp	12.6%+1.4pp	2.7%-1.6pp	-0.9%+3.9pp	14.1%+2.4pp	11.2%+0.8pp	4.3%+2.9pp	-4.8%-6.1pp
Net Margin	10.2%+0.3pp	8.8%+1.1pp	1.1%-1.0pp	-1.5%+3.6pp	9.9%+1.9pp	7.6%+0.7pp	2.1%+2.1pp	-5.1%-5.5pp
Return on Equity	5.1%-0.8pp	4.8%+0.7pp	0.4%-0.5pp	-0.6%+1.6pp	6.0%+1.0pp	4.1%0.0pp	0.9%+0.9pp	-2.2%-2.4pp
Return on Assets	2.4%-0.2pp	2.1%+0.4pp	0.2%-0.2pp	-0.3%+0.7pp	2.6%+0.4pp	1.8%0.0pp	0.4%+0.4pp	-1.0%-1.0pp
Current Ratio	3.79+0.2x	3.45+0.1x	3.420.0x	3.670.0x	3.56-0.1x	3.310.0x	3.470.0x	3.66-0.1x
Debt-to-Equity	0.68-0.1x	0.72-0.1x	0.760.0x	0.750.0x	0.750.0x	0.770.0x	0.780.0x	0.76-0.1x
Asset Turnover	0.230.0x	0.240.0x	0.170.0x	0.190.0x	0.260.0x	0.230.0x	0.190.0x	0.190.0x
FCF Margin	35.7%+9.5pp	-6.6%+0.3pp	-13.1%-1.7pp	25.3%-3.5pp	26.2%-1.2pp	-6.9%-3.1pp	-11.4%+1.2pp	28.8%+10.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Central Garden & Pet Company CENTA	FY2025	$3.1B	$162.8M	5.2%	$2.2B	59/100
Central Garden and Pet Co CENT	FY2025	$3.1B	$162.8M	5.2%	$2.5B	59/100
J&J Snack Foods Corp JJSF	FY2025	$1.6B	$65.6M	4.1%	$1.5B	63/100
Freshpet, Inc. FRPT	FY2025	$1.1B	$139.1M	12.6%	$3.1B	53/100
Flowers Foods, Inc. FLO	FY2025	$5.3B	$83.8M	1.6%	$1.2B	37/100

Where Central Garden & Pet Company Ranks

Frequently Asked Questions

What is Central Garden & Pet Company's annual revenue?

Central Garden & Pet Company (CENTA) reported $3.1B in total revenue for fiscal year 2025. This represents a -2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Central Garden & Pet Company's revenue growing?

Central Garden & Pet Company (CENTA) revenue declined by 2.2% year-over-year, from $3.2B to $3.1B in fiscal year 2025.

Is Central Garden & Pet Company profitable?

Yes, Central Garden & Pet Company (CENTA) reported a net income of $162.8M in fiscal year 2025, with a net profit margin of 5.2%.

What is Central Garden & Pet Company's EBITDA?

Central Garden & Pet Company (CENTA) had EBITDA of $334.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Central Garden & Pet Company have?

As of fiscal year 2025, Central Garden & Pet Company (CENTA) had $882.5M in cash and equivalents against $1.2B in long-term debt.

What is Central Garden & Pet Company's gross margin?

Central Garden & Pet Company (CENTA) had a gross margin of 31.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Central Garden & Pet Company's operating margin?

Central Garden & Pet Company (CENTA) had an operating margin of 8.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Central Garden & Pet Company's net profit margin?

Central Garden & Pet Company (CENTA) had a net profit margin of 5.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Central Garden & Pet Company's return on equity (ROE)?

Central Garden & Pet Company (CENTA) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Central Garden & Pet Company's free cash flow?

Central Garden & Pet Company (CENTA) generated $291.1M in free cash flow during fiscal year 2025. This represents a -17.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Central Garden & Pet Company's operating cash flow?

Central Garden & Pet Company (CENTA) generated $332.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Central Garden & Pet Company's total assets?

Central Garden & Pet Company (CENTA) had $3.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Central Garden & Pet Company's capital expenditures?

Central Garden & Pet Company (CENTA) invested $41.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Central Garden & Pet Company buy back shares?

Yes, Central Garden & Pet Company (CENTA) spent $155.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Central Garden & Pet Company's current ratio?

Central Garden & Pet Company (CENTA) had a current ratio of 3.67 as of fiscal year 2025, which is generally considered healthy.

What is Central Garden & Pet Company's debt-to-equity ratio?

Central Garden & Pet Company (CENTA) had a debt-to-equity ratio of 0.75 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Central Garden & Pet Company's return on assets (ROA)?

Central Garden & Pet Company (CENTA) had a return on assets of 4.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Central Garden & Pet Company's P/E ratio?

Central Garden & Pet Company (CENTA) trades at 13.2x earnings, its market capitalization divided by net income of $166.3M net income, trailing 12 months to June 27, 2026. The market capitalization is $2.2B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Central Garden & Pet Company's price-to-sales ratio?

Central Garden & Pet Company (CENTA) trades at 0.7x sales, its market capitalization divided by revenue of $3.1B revenue, trailing 12 months to June 27, 2026. The market capitalization is $2.2B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Central Garden & Pet Company's Altman Z-Score?

Central Garden & Pet Company (CENTA) has an Altman Z-Score of 2.60, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Central Garden & Pet Company's Piotroski F-Score?

Central Garden & Pet Company (CENTA) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Central Garden & Pet Company's earnings high quality?

Central Garden & Pet Company (CENTA) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Central Garden & Pet Company cover its interest payments?

Central Garden & Pet Company (CENTA) has an interest coverage ratio of 4.33x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Central Garden & Pet Company?

Central Garden & Pet Company (CENTA) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.